Canadian Urological Association (CUA)

Practice Changing Publications (PCP): Update in Kidney Cancer

Episode Summary

Practice Changing Publications (PCP): Update in Kidney Cancer

Episode Notes

Disclosures:

Anil Kapoor
Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca
Speakers Bureau: Merck, Ipsen, Eisai
Investments: Verity, Point Biopharma
Clinical Trials: CCTG, Eisai, Janssen, Merck
Leadership/Board Position: Kidney Cancer Canada

Luke Lavallee
Advisory Board: Sanofi, Ferring, Knight, Bayer, Janssen, Astellas
Grant/Honorarium: Sanofi